The Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP) regulates the manufacturing, marketing, and distribution of tobacco products. Our goal is to reduce the harm from all regulated tobacco products across the entire population, including: reducing the number of people who start to use tobacco products, encouraging more people to stop using these products, and reducing the adverse health impact for those who continue to use these products. CTP's actions have significant public health and consumer protection impact and are among the most important issues faced by the Agency in its long and distinguished history.
This position is located in the Department of Health and Human Services (DHHS), Food and Drug Administration (FDA), Office of Medical Products and Tobacco, Center for Tobacco Products (CTP), Office of Science (OS) located in Beltsville, Maryland.
Reviews a wide range of tobacco products to determine the adequacy of the results from biology, toxicology, environmental science, computational modeling, and/or other scientific studies.
Reviews and evaluates the results of nonclinical pharmacological studies submitted in support of tobacco products applications.
Provides advisory service to other offices within CTP, other FDA centers, and possible other agencies within the government.
Prepares comprehensive summaries and integrated discussions of data submitted for review and other available information.
The position of Pharmacologist falls under the 0405 occupational series. To qualify for this position at grade GS-11/12, you must meet the following:
Basic Requirements Applicants must have a major in an appropriate biological, medical, veterinary, or physical science, or in pharmacy that included at least 30 semester hours in chemistry and physiology and 12 semester hours in pharmacology.
NOTE: Applicants must submit all relevant transcripts that demonstrate you possess the required education to meet the Basic Qualifications.
Specialized Experience. Specialized experience is experience that equipped the applicant with the particular knowledge, skills, and abilities to perform successfully the duties of the position, and that is typically in or related to the work of the position to be filled.
GS-11 Have one year of specialized experience, equivalent to the GS-9 grade level in the Federal service, to include experience assisting with analyzing and evaluating nonclinical pharmacology and/or toxicology studies and protocols on regulated products such as drugs, chemicals or tobacco.
Have a Ph.D. or equivalent doctoral degree or 3 academic years of progressively higher level graduate education leading towards a Ph.D. or LL.M., if related. (Must submit transcripts)
Have a combination of experience as described in "A" above and education as described in "B" above.
GS-12 Have one year of specialized experience, equivalent to the GS-11 grade level in the Federal service, to include experience assisting in reviewing, evaluating, designing, developing or validating scientific documents and protocols of nonclinical pharmacology and/or toxicology studies related to products such as drugs, chemicals or tobacco.
All qualification requirements must be met by 11:59 pm (Eastern Time) on 02/05/2021. If, after reviewing your resume and/or supporting documentation, a determination is made that you have inflated your responses when compared to your background information, you may be deemed ineligible or your score may be adjusted to more accurately reflect your skills and abilities. You must continue to meet all requirements through the hiring process.
Internal Number: 1
About FDA The Center for Tobacco Products
The Center for Tobacco Products (CTP) Director is responsible for planning, managing, directing and coordinating major tobacco program objectives to support the Family Smoking Prevention and Tobacco Control Act. This law gives FDA authority over tobacco products by adding a new chapter to the Food, Drug and Cosmetic Act for tobacco products and reinstating the 1996 final rule. Some of the Agency’s responsibilities under the law include setting product standards, reviewing premarket applications for new and modified risk tobacco products, requiring new health warning labels, and establishing and enforcing advertising and promotion restrictions. The law gives FDA the authority to regulate tobacco products and manufacturers - not growers. The actions outlined in the final rule are expected to have significant public health and consumer protection impact, and are among the most important issues faced by the Agency in its long and distinguished history.